Does your GLP-1 medication actually 'stall' and can you fix it?

What did @drjonesdc actually say?

The claim, stripped down: if your GLP-1 medication has stopped producing weight loss, a weekly 24-hour fast will "immediately" fix insulin resistance and restart fat burning. He describes it as "hitting a metabolic magic reset" and frames it as the most powerful lifestyle intervention available for insulin resistance. He recommends starting with time-restricted eating (an 8-hour window), then graduating to one full 24-hour fast per week. His credentials are listed as DC, meaning Doctor of Chiropractic, not an MD, DO, or registered dietitian. That matters for context.

He also attributes weight-loss plateaus specifically to insulin resistance that GLP-1 drugs only partially address. His solution is fasting as an add-on intervention. The "link in bio" suggests this leads to a paid service.

Does the science back this up?

Partially, and the devil is genuinely in the details. Fasting does improve insulin sensitivity, and there is real evidence behind that. But "immediately" and "magic reset" are doing a lot of heavy lifting here that the data does not support.

A 2022 randomized controlled trial by Lowe et al. in the New England Journal of Medicine found that time-restricted eating alone produced modest weight loss but no statistically significant improvement in metabolic markers over calorie restriction alone. On the other hand, a 2019 study by Sutton et al. in Cell Metabolism showed that early time-restricted feeding (independent of caloric intake) improved insulin sensitivity in men with prediabetes. So fasting has metabolic benefits, but the framing of "immediate" and dramatic fat-burning activation overstates what the research actually shows. The effect sizes are real but modest, and individual response varies considerably.

GLP-1 receptor agonists do improve insulin sensitivity through multiple pathways, including slowing gastric emptying and improving pancreatic beta-cell response. The idea that fasting adds something on top of that is plausible, but there are no published trials specifically examining weekly 24-hour fasting as an adjunct to semaglutide or tirzepatide therapy during a weight plateau.

What did they get wrong (or right)?

Credit where it is due: the general direction is not wrong. Fasting improves insulin sensitivity in the evidence base, and combining lifestyle interventions with GLP-1 therapy is standard practice. He is not telling people to stop their medication, which is good.

What he gets wrong is the certainty and the mechanism framing. Calling it a "metabolic magic reset" is the kind of language that gets people into trouble. Weight-loss plateaus on GLP-1 drugs are multifactorial. They involve adaptive thermogenesis, changes in lean mass, medication dose, dietary composition, sleep, and stress, not just insulin resistance. Pinning it all on insulin resistance and one weekly fast is reductive and potentially misleading to patients who might ignore other factors that need clinical attention.

The biggest red flag: he says "inflammation improves, fat burning kicks into overdrive" after a 24-hour fast. That is not how this works on a single-episode basis. Acute fasting does reduce some inflammatory markers, but the phrase "kicks into overdrive" implies a sustained metabolic shift that a single weekly fast does not reliably produce. That is an exaggeration.

What should you actually know?

If your GLP-1 medication has stalled, the first call should be to whoever prescribed it, not a chiropractor's TikTok. Dose adjustments, injection site rotation, medication adherence, and dietary protein intake are all clinically validated levers that a prescriber can actually address. Fasting may be a reasonable adjunct for some people, but it is not appropriate for everyone on GLP-1 therapy. People with a history of eating disorders, hypoglycemia risk, or certain cardiovascular conditions should not start 24-hour fasting protocols without medical clearance.

Time-restricted eating has a reasonable evidence base. A 2020 review by Cienfuegos et al. in Obesity demonstrated meaningful improvements in insulin resistance with alternate-day and 5:2 fasting protocols. But "meaningful" in clinical trials usually means statistically significant, not dramatic. Managing expectations here is important. If you want to try intermittent fasting alongside your GLP-1 medication, discuss it with your prescribing clinician first. Do not treat a viral TikTok as a prescription.